CRISPR/Cas9‑induced saturated mutagenesis identifies <i>Rad51</i> haplotype as a marker of PARP inhibitor sensitivity in breast cancer.

Mol Med Rep · 2022 · PMC9309539 · PMID 35713220

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

P<0.05 and P<0.01 were considered statistically significant and highly significant, respectively.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.